PUBLISHER: IMARC | PRODUCT CODE: 1819862
PUBLISHER: IMARC | PRODUCT CODE: 1819862
United States Platelet Rich Plasma Market Report by Product Type (Pure Platelet-Rich Plasma, Leukocyte- and Platelet-Rich Plasma, Leukocyte- and Platelet-Rich Fibrin, Pure Platelet-Rich Fibrin ), Origin, Application, End User, and Region 2025-2033
The United States platelet rich plasma market size reached USD 271.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 581.2 Million by 2033, exhibiting a growth rate (CAGR) of 8.38% during 2025-2033.
United States platelet rich plasma Market Trends:
Growing Demand for Minimally Invasive and Regenerative Therapies
The rising preference for minimally invasive treatments is a key driver of the United States platelet rich plasma market trends. Patients and healthcare providers increasingly seek therapies that promote natural healing without surgical intervention. PRP, derived from the patient's own blood, fits well within regenerative medicine due to its potential to accelerate tissue repair, reduce inflammation, and enhance recovery. This demand is particularly high in orthopedics, sports medicine, and aesthetics, where patients aim to avoid the risks and downtime of surgery. Additionally, the aging population is contributing to a higher incidence of degenerative conditions such as osteoarthritis, further boosting interest in regenerative approaches like PRP. The therapy's low risk of immunogenic response and its personalized nature appeal to both providers and patients, making it a preferred option across multiple specialties seeking non-invasive, effective alternatives.
Technological Advancements in PRP Preparation Systems
Advancements in PRP processing technology have significantly improved the consistency, efficiency, and safety of PRP treatments, thus driving market adoption in the U.S. Modern automated centrifuge systems and closed-loop devices have streamlined PRP extraction, allowing for better control of platelet concentration and preparation time. These developments improve reproducibility, lower operator error, and increase procedure accessibility in office-based or outpatient settings. Furthermore, physicians from a variety of specialties, such as dentistry, orthopedics, and dermatology, can now employ PRP with no training thanks to easy-to-use kits. Depending on the clinical indication, customized applications are now possible thanks to the discovery of leukocyte-rich and leukocyte-poor PRP variants. As technology continues to evolve, the standardization of PRP products becomes more achievable, supporting wider clinical use and improving patient outcomes. These technological strides make PRP not only more practical but also more appealing as a mainstream therapeutic tool.
Rising Incidence of Sports Injuries and Musculoskeletal Disorders
The growing number of sports-related injuries and musculoskeletal conditions in the United States platelet rich plasma market analysis. Active lifestyles, especially among young adults and aging baby boomers, contribute to a high prevalence of tendonitis, ligament tears, and joint degeneration. PRP is widely used in sports medicine to accelerate healing and reduce downtime in athletes, both amateur and professional. Likewise, orthopedic conditions such as osteoarthritis and chronic back pain affect millions, prompting interest in alternatives to steroids and surgery. PRP has shown promise in reducing pain and improving function in these patients by enhancing the body's natural healing processes. Its ability to delay or replace invasive interventions makes it attractive in both preventative and therapeutic contexts. This rising burden of musculoskeletal disorders ensures a strong and growing demand for innovative biologic treatments like PRP.
Key Market Segmentation:
Breakup by Product Type:
- Pure Platelet-Rich Plasma (P-PRP)
- Leukocyte- and Platelet-Rich Plasma (LPRP)
- Leukocyte- and Platelet-Rich Fibrin (L-PRF)
- Pure Platelet-Rich Fibrin (P-PRF)
Breakup by Origin:
- Autologous PRP
- Homologous PRP
- Allogeneic PRP
Breakup by Application:
- Orthopedics
- Cosmetic Surgery and Dermatology
- Neurosurgery
- General Surgery
- Cardiothoracic Surgery
- Urology
- Ophthalmology
- Others
Breakup by End User:
- Hospitals and Clinics
- Research Institutes
- Others
Breakup by Region:
- Northeast
- Midwest
- South
- West
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Arteriocyte Medical Systems Inc. (Isto Technologies II LLC), Arthrex Inc., Depuy Synthes, Inc. (Johnson & Johnson), Dr Prp USA LLC, EmCyte Corporation, Exactech Inc., Glofinn America LLC (Glofinn Co. Ltd.), Regen Lab USA LLC, Stryker Corporation, Terumo BCT Inc. (Terumo Corporation), ThermoGenesis Holdings Inc. and Zimmer Biomet Holdings Inc.
Key Questions Answered in This Report
- 1.What was the size of the United States platelet rich plasma market in 2024?
- 2.What is the expected growth rate of the United States platelet rich plasma market during 2025-2033?
- 3.What are the key factors driving the United States platelet rich plasma market?
- 4.What has been the impact of COVID-19 on the United States platelet rich plasma market?
- 5.What is the breakup of the United States platelet rich plasma market based on the product type?
- 6.What is the breakup of the United States platelet rich plasma market based on the origin?
- 7.What is the breakup of the United States platelet rich plasma market based on the application?
- 8.What is the breakup of the United States platelet rich plasma market based on the end user?
- 9.What are the key regions in the United States platelet rich plasma market?
- 10.Who are the key players/companies in the United States platelet rich plasma market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 United States Platelet Rich Plasma Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Pure Platelet-Rich Plasma (P-PRP)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Leukocyte- and Platelet-Rich Plasma (LPRP)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Leukocyte- and Platelet-Rich Fibrin (L-PRF)
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Pure Platelet-Rich Fibrin (P-PRF)
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Origin
- 7.1 Autologous PRP
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Homologous PRP
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Allogeneic PRP
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Application
- 8.1 Orthopedics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Cosmetic Surgery and Dermatology
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Neurosurgery
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 General Surgery
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Cardiothoracic Surgery
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Urology
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
- 8.7 Ophthalmology
- 8.7.1 Market Trends
- 8.7.2 Market Forecast
- 8.8 Others
- 8.8.1 Market Trends
- 8.8.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Research Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 Northeast
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Midwest
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 South
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
- 10.4 West
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Arteriocyte Medical Systems Inc. (Isto Technologies II LLC)
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 SWOT Analysis
- 15.3.2 Arthrex Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Depuy Synthes Inc. (Johnson & Johnson)
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.4 Dr Prp USA LLC
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 EmCyte Corporation
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Exactech Inc.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Glofinn America LLC (Glofinn Co. Ltd.)
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Regen Lab USA LLC
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Stryker Corporation
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Terumo BCT Inc. (Terumo Corporation)
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 ThermoGenesis Holdings Inc.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.12 Zimmer Biomet Holdings Inc.
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
- 15.3.1 Arteriocyte Medical Systems Inc. (Isto Technologies II LLC)
List of Figures
- Figure 1: United States: Platelet Rich Plasma Market: Major Drivers and Challenges
- Figure 2: United States: Platelet Rich Plasma Market: Sales Value (in Million USD), 2019-2024
- Figure 3: United States: Platelet Rich Plasma Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 4: United States: Platelet Rich Plasma Market: Breakup by Product Type (in %), 2024
- Figure 5: United States: Platelet Rich Plasma Market: Breakup by Origin (in %), 2024
- Figure 6: United States: Platelet Rich Plasma Market: Breakup by Application (in %), 2024
- Figure 7: United States: Platelet Rich Plasma Market: Breakup by End User (in %), 2024
- Figure 8: United States: Platelet Rich Plasma Market: Breakup by Region (in %), 2024
- Figure 9: United States: Platelet Rich Plasma (Pure Platelet-Rich Plasma (P-PRP)) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 10: United States: Platelet Rich Plasma (Pure Platelet-Rich Plasma (P-PRP)) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 11: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Plasma (LPRP)) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 12: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Plasma (LPRP)) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 13: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Fibrin (L-PRF) ) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 14: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Fibrin (L-PRF) ) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 15: United States: Platelet Rich Plasma (Pure Platelet-Rich Fibrin (P-PRF)) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 16: United States: Platelet Rich Plasma (Pure Platelet-Rich Fibrin (P-PRF)) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 17: United States: Platelet Rich Plasma (Autologous PRP) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 18: United States: Platelet Rich Plasma (Autologous PRP) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 19: United States: Platelet Rich Plasma (Homologous PRP) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 20: United States: Platelet Rich Plasma (Homologous PRP) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 21: United States: Platelet Rich Plasma (Allogeneic PRP) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 22: United States: Platelet Rich Plasma (Allogeneic PRP) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 23: United States: Platelet Rich Plasma (Orthopedics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 24: United States: Platelet Rich Plasma (Orthopedics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 25: United States: Platelet Rich Plasma (Cosmetic Surgery and Dermatology) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 26: United States: Platelet Rich Plasma (Cosmetic Surgery and Dermatology) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 27: United States: Platelet Rich Plasma (Neurosurgery) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 28: United States: Platelet Rich Plasma (Neurosurgery) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 29: United States: Platelet Rich Plasma (General Surgery) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 30: United States: Platelet Rich Plasma (General Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 31: United States: Platelet Rich Plasma (Cardiothoracic Surgery) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 32: United States: Platelet Rich Plasma (Cardiothoracic Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 33: United States: Platelet Rich Plasma (Urology) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 34: United States: Platelet Rich Plasma (Urology) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 35: United States: Platelet Rich Plasma (Ophthalmology) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 36: United States: Platelet Rich Plasma (Ophthalmology) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 37: United States: Platelet Rich Plasma (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 38: United States: Platelet Rich Plasma (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 39: United States: Platelet Rich Plasma (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 40: United States: Platelet Rich Plasma (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 41: United States: Platelet Rich Plasma (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 42: United States: Platelet Rich Plasma (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 43: United States: Platelet Rich Plasma (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 44: United States: Platelet Rich Plasma (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 45: Northeast: Platelet Rich Plasma Market: Sales Value (in Million USD), 2019 & 2024
- Figure 46: Northeast: Platelet Rich Plasma Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 47: Midwest: Platelet Rich Plasma Market: Sales Value (in Million USD), 2019 & 2024
- Figure 48: Midwest: Platelet Rich Plasma Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 49: South: Platelet Rich Plasma Market: Sales Value (in Million USD), 2019 & 2024
- Figure 50: South: Platelet Rich Plasma Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 51: West: Platelet Rich Plasma Market: Sales Value (in Million USD), 2019 & 2024
- Figure 52: West: Platelet Rich Plasma Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 53: United States: Platelet Rich Plasma Industry: SWOT Analysis
- Figure 54: United States: Platelet Rich Plasma Industry: Value Chain Analysis
- Figure 55: United States: Platelet Rich Plasma Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: United States: Platelet Rich Plasma Market: Key Industry Highlights, 2024 and 2033
- Table 2: United States: Platelet Rich Plasma Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
- Table 3: United States: Platelet Rich Plasma Market Forecast: Breakup by Origin (in Million USD), 2025-2033
- Table 4: United States: Platelet Rich Plasma Market Forecast: Breakup by Application (in Million USD), 2025-2033
- Table 5: United States: Platelet Rich Plasma Market Forecast: Breakup by End User (in Million USD), 2025-2033
- Table 6: United States: Platelet Rich Plasma Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 7: United States: Platelet Rich Plasma Market: Competitive Structure
- Table 8: United States: Platelet Rich Plasma Market: Key Players
